The Oncidium foundation is launching ‘RLT-Connect‘, a revolutionary platform connecting healthcare professionals with Radioisotope suppliers to provide radioligand therapy to cancer patients in need. This game-changing initiative aims to break down financial barriers and ensure equitable access to life-saving treatments. By fostering collaborations and financing a portion of treatments, the foundation is committed to making a global impact.
Join us in this mission to save lives and learn more about the project at booth #248 at the EANM Annual Meeting 2023.
Do not miss Alice’s presentation of the platform everyday at 1pm CEST at booth #248!
Register your email address to be informed of the full-scale deployment in 2024.